» Articles » PMID: 22262242

Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: Comparison of Ventilation/perfusion Scanning and Multidetector Computed Tomography Pulmonary Angiography with Pulmonary Angiography

Overview
Journal Nucl Med Commun
Specialty Nuclear Medicine
Date 2012 Jan 21
PMID 22262242
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The correct and prompt diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) plays a pivotal role in determining appropriate therapy. This study aimed to compare the diagnostic efficacy of pulmonary ventilation/perfusion (V/Q) scanning and computed tomography pulmonary angiography (CTPA) using pulmonary angiography as the golden standard.

Methods: A total of 114 consecutive patients (49 men and 65 women, age 43.3 ± 15.3 years) suspected of having CTEPH were prospectively enrolled. All patients underwent V/Q scanning, CTPA, and pulmonary angiography within an interval of 7 days from one another. Interpretation of V/Q images was based on the refined Pulmonary Embolism Diagnosis criteria. For threshold 1, high-probability and intermediate-probability V/Q scan findings were considered to be positive, and low-probability/normal V/Q scan findings were negative. For threshold 2, only a high-probability V/Q scan finding was considered to be positive, and intermediate-probability and low-probability/normal V/Q scan findings were considered to be negative.

Results: Fifty-one patients (44.7%) had a final diagnosis of CTEPH. V/Q scan showed high probability, intermediate probability, and low probability/normal scan in 52, three, and 59 patients, respectively. CTPA revealed 50 patients with CTEPH and 64 patients without CTEPH. The sensitivity, specificity, and accuracy of the V/Q scan were 100, 93.7, and 96.5%, respectively, with threshold 1, and 96.1, 95.2, and 95.6%, respectively, with threshold 2; similarly, the sensitivity, specificity, and accuracy of CTPA were 92.2, 95.2, and 93.9%, respectively.

Conclusion: In conclusion, both V/Q scanning and CTPA are accurate methods for the detection of CTEPH with excellent diagnostic efficacy.

Citing Articles

CT imaging biomarkers to predict severity and prognosis of pulmonary hypertension.

Yoon D, Yoon Y, Hwang I, Lee W, Lee K, Chun E PLoS One. 2025; 20(2):e0313235.

PMID: 39937766 PMC: 11819466. DOI: 10.1371/journal.pone.0313235.


The Role of Imaging in Pulmonary Vascular Disease: The Clinician's Perspective.

Jakubowski B, Griffiths M, Goss K Radiol Clin North Am. 2025; 63(2):305-313.

PMID: 39863382 PMC: 11763221. DOI: 10.1016/j.rcl.2024.07.008.


Pulmonary hypertension in adults with congenital heart defects (ACHDs)-in light of the 2022 ESC PAH guidelines-part I: definition, epidemiology, classification, diagnostics, genetics, risk stratification and follow-up, gender aspects.

Kaemmerer H, Diller G, Dahnert I, Achenbach S, Eichstaedt C, Eicken A Cardiovasc Diagn Ther. 2024; 14(5):935-948.

PMID: 39513141 PMC: 11538847. DOI: 10.21037/cdt-24-148.


Chronic thromboembolic pulmonary hypertension: the diagnostic assessment.

Simeone B, Maggio E, Schirone L, Rocco E, Sarto G, Spadafora L Front Cardiovasc Med. 2024; 11:1439402.

PMID: 39309600 PMC: 11412851. DOI: 10.3389/fcvm.2024.1439402.


Definition, classification and diagnosis of pulmonary hypertension.

Kovacs G, Bartolome S, Denton C, Gatzoulis M, Gu S, Khanna D Eur Respir J. 2024; 64(4).

PMID: 39209475 PMC: 11533989. DOI: 10.1183/13993003.01324-2024.